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BACKGROUND: Urinary tract infection (UTI) is commonly experienced by women of various age 
groups especially elderly ones. We planned to find out the prevalent microbial strains causing UTI in 
slum inhabitant adolescent and adult women in Dhaka City, Bangladesh.  
METHODS AND MATERIALS: Urine sample was collected from 462 UTI suspected female subjects. 
Pathogenic bacteria were identified using standard microbiological tests, and antimicrobial sensitivity 
profiles of the pathogens were determined. 
RESULTS: Bacteriuria was present in 9% of the subjects. A higher incidence (16.8%) of UTI was noted 
among adult women aged above 19 years. Escherichia coli (69%), Streptococcus spp. (15%) and 
Pseudomonas aeruginosa (7%) were more frequently isolated from the urine samples compared to 
Enterococcus faecalis (3%), Staphylococcus aureus (2%), Klebsiella pneumoniae (2%) and Hafnia alvei 
(2%). The E. coli isolates showed complete resistance to commonly used drugs, and 58% of these isolates 
were multidrug resistant (MDR). Minimum Inhibitory Concentration (MIC) values for ciprofloxacin 
ranged between 64µg/ml and 512µg/ml, and the Minimum Bactericidal Concentration (MBC) values 
against the isolates were 128µg/ml or above. Isolated strains of E. coli exhibited equal extent of 
ciprofloxacin resistance irrespective of the presence or absence of plasmid in them.  
CONCLUSION: The extent of drug resistance among the uropathogens if ignored may render them 
uncontrollable. This study suggests regular monitoring of drug resistance phenotype of the UTI 
pathogens to reduce the morbidity of female UTI patients and offer better treatment strategy in the 
healthcare sectors of Bangladesh.  






Acute UTI occurs in many women each year, and 
the annual costs of caring for those women are 
invariably very high in Bangladesh. 
Approximately, 60% of all women experience at 
least one UTI within their lifetime and roughly 20-
30% women suffer from repeated infections (1, 2). 
Sexual activities of women have been considered 
as important risk factors for UTI infections and 
recurrences (3), and with as frequently early 
marriage occurs in the slum women in 
Bangladesh, UTI may be promoted. In post-
menopausal women, UTI risk factors may also 
comprise urinary incontinence (4). Bacterial 
virulence properties may affect the risk of 
recurrence of infection as well
 
(5).  
 UTI is commonly caused by Escherichia 
coli, Proteus, Klebsiella, Enterococcus, and 
Enterobacter spp. (6). However, Pseudomonas,
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Staphylococcus aureus, Group B Streptococcus 
are usually reported with increased rates in 
patients with urological disorders and following 
repetitive courses with antibiotic treatments
 
(7). 
Uropathogenic E. coli utilize a number of 
virulence factors to adherence the uroepithelial 
cells; however, the strains fit to a limited number 
of serogroups mainly to O1, O2, O4, O6, O7, O14, 
O15, O18, O22 and O75
 
(8, 9). Anti-microbial 
resistance among uropathogenic E. coli may be 
increased with temporal and geographic 
fluctuations which may introduce multidrug 
resistant E. coli into the community (10). In recent 
years, an increased number of Extended-
Spectrum-Beta-Lactamases (ESBL) producing 
pathogens have been observed in outpatient 
settings, especially related to urinary tract 
infections (UTI), narrowing the treatment option 
with antibiotics (11). 
In addition to age, sex, marital and social 
status, other risk factors include nature and type of 
strains associated with UTI. For example, Shiga 
toxin-producing E. coli may contribute to 
hemolytic uremic syndrome, elevated white blood 
cell count and C-reactive protein levels
 
in infected 
patients (12). Little is known about the 
pathogenesis, natural history, risk factors, and 
epidemiology of the multi-drug resistant UTI 
pathogens of slum adolescent and adult women 
origin in Bangladesh. Therefore, we designed our 
study to determine the prevalence, drug resistance 
phenotype and plasmid profile of the 
uropathogens.  
 
MATERIALS AND METHODS 
 
Study population and sample : The study 
included UTI suspected female subjects living in 
slums located around the Dhaka City, Bangladesh. 
Urine sample was collected from February 2011 to 
December 2011. Individuals were requested to fill 
out a questionnaire regarding their consent, 
morbidity and recent history of medication. 
Subjects receiving antimicrobial treatment for 
existing complications were excluded from this 
study. One midstream-urine sample per female 
subject was collected and examined by standard 
quantitative culture methods
 
(13). Positive culture 
was defined as the culture of a single 
microorganism at a concentration of 10
5
 colony-
forming units (CFU)/ml (14). In cases of delay in 
processing, the samples were stored at 4
o
C.  
Identification of the uropathogens: 
Nutrient agar plates were used for total bacterial 
count of the urine samples and uropathogens were 
isolated on Blood agar and MacConkey agar 
media. All the plates were incubated aerobically at 
37
o
C for 24-48 hours and the colonies were 
enumerated. For confirmation of specific bacterial 
spp., standard biochemical tests were performed.  
Serogrouping: The uropathogenic E. coli 
isolates were serotyped using different 
monovalent O-antisera (Eurobio, France) which 
have association with human infection. Strains 
that did not display agglutination with any of the 
13 used O-antisera were defined as O non-typed 
(5, 8).   
Antimicrobial susceptibility testing: 
Antimicrobial susceptibility testing of the isolated 
bacterial spp. was performed by disc diffusion 
method following the National Committee for 
Clinical Laboratory Standards (NCCLS) 
guidelines
 
(15). Standard strains of Escherichia 
coli ATCC 25922, Enterococcus faecalis 29212, 
Pseudomonas aeruginosa ATCC 27853 and 
Staphylococcus aureus ATCC 25923 were used 
for quality control. For this study, we presented 
susceptibility data for ampicillin (10g), 
azithromycin (15g), doxycycline (30g), 
nalidixic acid (30g), amoxicillin (10g), 
tetracycline (30g), cephalexin (30g), 
ciprofloxacin (5g), levofloxacin (5g), imipenem 
(10g), meropenem (10g), amikacin (30g), 
nitrofurantoin (300g), netilmicine (30g), 
gentamicin (10g) and ceftriaxone (30g). 
Defining multidrug resistant (MDR) 
strains: MDR in Enterobacteriaceae is defined as 
resistance to at least one drug from three or more 
of the following antimicrobial categories: 
aminoglycosides (e.g., gentamicin, tobramycin, 
amikacin or netilmicin), carbapenems (imipenem, 
meropenem, ertapenem or doripenem), 
fluoroquinolones (e.g., ciprofloxacin), penicillins 
(e.g., ampicillin) and tetracyclines (e.g., 
tetracycline, doxycycline or minocycline) etc. 
(16).  
Minimum inhibitory concentration (MIC): 
MIC is the lowest concentration of antimicrobial 
drug that inhibits visible growth of the test 
organism as outlined by the NCCLS
 
(15). 
Minimum inhibitory concentrations (MICs) of the 




selected ciprofloxacin resistant isolates were 
determined in Mueller-Hinton broth
 
by macro-
broth dilution technique (17). The lowest 
concentration of antibiotic that killed 100% of the 
test organism on solid media was taken as 
minimum bactericidal concentration (MBC) for 
the bacterium. 
Plasmid profiling: Alkaline lysis method 
was followed to extract plasmid DNA from the 
isolated pathogens (18)
 
and the molecular weight 
of the unkwon plasmid was determined by agarose 
(0.8%) gel electrophoresis method comparing the 
pattern of migration with that of known plasmid 
markers.  
Plasmid curing and plasmid profile 
analysis: Plasmid curing for the selected isolates 
was performed according to Tomeda, et al. (1968)
 
(19), and then the isolates were transferred onto 
30µg of ciprofloxacin containing plates. After 
overnight incubation, colonies which appeared on 
ciprofloxacin plates were assumed as strains 
bearing drug resistance genes in their 
chromosome. To confirm the absence of plasmid 
in the cured isolates, plasmid DNA extraction 
procedure was performed by the technique 
mentioned in the previous section.  
RESULTS 
 
A total of 462 female subjects suspected of having 
urinary tract infection were included in this study; 
of them 42 (9%) had significant bacteriuria. 
Among the 42 positive cases, 29 were adult 
women (aged >19 years), 11 were adolescents 
(aged between 10-19 years) and the remaining two 
were children (aged <10 years). UTI prevalence in 
adult subjects (n=173) was 16.8%, but 6.6% in 
adolescents (n=167).  Therefore, UTI prevalence 
between adult and adolescent women was 
significantly different (p=0.001). A complex 
microbial population as shown in figure 1 was 
identified from the urine sample. Escherichia coli 
(69%), Streptococcus spp. (15%) and 
Pseudomonas aeruginosa (7%) were most 
common, while Enterococcus faecalis (3%), 
Staphylococcus aureus (2%), Klebsiella 
pneumoniae (2%) and Hafnia alvei (2%) were less 
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Figure 1: Distribution of uropathogens (n=42) 
among the slum women in Dhaka city, Bangladesh  
 
All the 29 E. coli isolates were grouped with 
O-antisera where six strains (20.69%) were non-
typable. Serogroup O6 was most frequently 
identified (24.14%) that was followed by 
serogroup O20 (13.79%) and O18 (10.34%) 
(Table 1). In total, these three serogroups (O6, 
O20 and O18) consisted of 48.28% of all E. coli 
isolates.  
 
Table 1: Frequency of E. coli serogroups in UTI 























Serogroup Number Percent 
O1 2 6.90 
O6 7 24.14 
O8 2 6.90 
O15 2 6.90 
O18 3 10.34 
O20 4 13.79 
O25 1 3.45 
O55 1 3.45 
O78 0 0.00 
O86 0 0.00 
O111 0 0.00 
O119 0 0.00 
O125 1 3.45 
Non-typed 6 20.69 
Total 29 100.00 





The E. coli isolates of this study,  as represented in 
figure 2, were 100% resistant to ampicillin, 
azithromycin, doxycycline, 90% to nalidixic acid 
and amoxicillin, 70% to levofloxacin, 68% to 
ciprofloxacin and 65% to tetracycline and 
cephalexin. Conversely, lower resistance was 
recorded for imipenem (20%), meropenem (15%), 
amikacin (12%), and nitrofurantoin (10%). The E. 
coli isolates were completely (100%) sensitive to 

























































































Figure 2: Antibiotic resistance/sensitivity pattern of the Escherichia coli isolates (n = 29) 
 
Most of the isolated E. coli was found to be 
resistant to more than four test drugs (Table 2). 
Among the E. coli isolates, 17 (58%) were 
Multidrug Resistant, exhibiting their 
insensitiveness against ampicillin, doxycycline 
and ciprofloxacin, each belonging to different 
antibiotic groups. However, 11 (37.93%) of the E. 
coli isolates were resistant to five while two 
(6.89%) of them were resistant to seven different 
groups of antibiotic.  
 
Table 2: Drug resistant phenotypes of selected E. 
coli in UTI patients living in the slum of Dhaka 
city, Bangladesh 
 
 Percentage (% ) of 
resistant isolates  
Resistant phenotype† 
100%   AMP + DO 
58.62%  AMP + DO + CIP  
37.93%  AMP + DO + CIP + TET + CL  
6.89%  AMP + DO + CIP + TET + CL 
+ IM + AMK 
 
†AMP=Ampicillin;DO=Doxycycline; 
CIP=Ciprofloxacin; TET= Tetracycline; CL= 
Cephalexin; IM= Imipenem; AMK= Amikacin 
 
Among the multidrug resistant isolates, ten highly 
resistant strains were chosen for Minimum 
Inhibitory Concentration (MIC) determination 
against ciprofloxacin (Table 3). MIC values were 
lower with the range of 64-128 µg/ml. The 
Minimum Bactericidal Concentration (MBC) 
values against the isolates were 128 µg/ml or 
more.  
 
Table 3: MIC and MBC values for ciprofloxacin 
resistant E. coli in UTI patients living in the slum 




MIC (µg/ml) MBC (µg/ml) 
3 64 256 
5 128 256 
8 128 256 
9 64 >128 
11 128 256 
16 64 128 
18 128 256 
21 64 128 
23 64 >128 
27 128 256 
 




Plasmid profile of highly ciprofloxacin resistant E. 
coli isolates showed plasmids with variable size 
ranging from 140 to < 2 MDa (Figure 3), among 
them, four isolates were found to pose large 




Figure 3: Electrophoretic patterns of plasmid 
DNA from uropathogenic isolates of E. coli 
electrophoresed in 0.8% agarose gel; first lane 
showing Marker plasmid pDK9 and rests 
indicating isolate number. 
 
Plasmid was cured from the six selected isolates 
(isolate no. 3, 5, 8, 11, 18 and 27) and was grown 
on nutrient agar. These isolates showed no bands 
on agarose gel when plasmid DNA extraction 
procedure was performed. It emphasizes that the 
resistance of genes might be carried by the 




In Bangladesh, slums are population-dense 
residences with poor facilities of the basic 
requirements of life. Slum inhabitants reside in a 
highly polluted environment comprising of 
numerous pathogenic microorganisms. Thus, the 
lives of slum populations are always at risk of 
getting infected with various pathogenic microbes. 
Urinary tract infections (UTIs) are common in 
women, often associated with significant 
morbidity
 
and mortality (20), and may affect 
women of all age groups especially sexually active 
ones (21). We studied 462 urine samples and 
found UTI in about 9% cases where a higher 
incidence (16.8%) of UTI was noticed for adult 
women aged over 19 years. The frequency is close 
to the incidence reported by Ahmed and Avasarala 
(2008), i.e. 12.7% (22), but is higher than the 
study of Singh MM et al. (2001) (23) who 
reported 4.2% UTI in a community based study. In 
Bangladesh, Begum et al. (2006) (24) reported 
16.4% UTI in the female garments workers of 
Dhaka City. Patients in Bangladesh usually see a 
doctor after experiencing severe health 
complications for a particular disease condition. 
Therefore, Bashar et al. (2009) and Rahman et al. 
(2009) reported higher frequency of UTI i.e., 27% 
and 24.14% respectively in hospital or clinic based 
study  (25, 26).  
This study reports association of Escherichia 
coli (69%), Streptococcus spp. (15%), 
Pseudomonas aeruginosa (7%), Enterococcus 
faecalis (3%), Staphylococcus aureus (2%), 
Klebsiella pneumoniae (2%) and Hafnia alvei 
(2%) in UTI. Other investigators (Basar et al. 
2009, Saber et al. 2010, and Jan et al.(2009) also 
reported higher association of E. coli (66.67%, 
77.8% and 52.65% cases respectively) in UTI 
patients (25, 27-28). A major part of O-groupable 
E. coli strains mainly O1, O2, O4, O6, O7, O18 
and O75 have been reported to account for UTI in 
different parts of the world
 
(29). The 
uropathogenic E. coli isolates of this study mainly 
belong to one of 3 serogroups O6, O15 and O18. 
Strains belonging to these serogroups have been 
reported to pose specific virulence factors for their 
invasive ability
 
(29). The finding of this study 
nearly supports this theory. 
Antibiotic resistance among uropathogens has 
become a public health concern in Bangladesh
 
(30). Under individual predisposing conditions, E. 
coli can multiply rapidly in the urinary tract of an 
UTI patient. However, if the patient doesn’t 
maintain antibiotic dose regimen properly, the 
organism may emerge as drug resistant variant and 
eventually result in both community-and 
nosocomially acquired UTIs
 
(31, 32). The present 
study found the E. coli isolates to be completely 
resistant to the commonly used drugs such as 
penicillin group and also to a higher extent to 
broad spectrum quinolone group. A similar 
frequency among the UTI related E. coli isolates 
was recorded in some developing countries (33-
34). However, a lower frequency for the same 
pathogen was  reported from the isolates of developed 
countries
 
(35). Antibiotic abuse and practicing 
incomplete antibiotic regimen has considerably 





promoted the dissemination of multidrug resistant 
bacteria (36-37). This study reports lower 
resistance for less commonly used drugs like 
imipenem, meropenem, amikacin and 
nitrofurantoin, and complete sensitivity to 
netilmycine, gentamicin and ceftriaxone among 
the E. coli isolates. This finding is supported by 
the study of Sharmin et al. (2009) which reported 
a good sensitivity for imipenem, ceftazidime and 
amikacin against UTI-isolates of E. coli in 
Bangladesh (38). Encarnacion AR (2012) also 
reported sensitivity of the UTI-isolates of E. coli 
for amikacin in Philippines (39). This finding 
suggests the use of drugs that are less commonly 
prescribed by practitioners for arresting the 
pathogens in UTI patients may be beneficial. 
Multidrug resistance among the pathogenic 
microbes is a common problem which may be 
either plasmid-borne or chromosomal or 
sometimes both (40, 41). At least 17 of all the 
Escherichia coli isolates examined in this study 
exhibited multidrug resistance. Such multidrug 
resistance complicates empiric treatment of E. coli 
infections and may contribute plasmid mediated 
multidrug resistance transfer
 
(42). The present 
study demonstrated chromosome-borne resistance 
for ciprofloxacin since the E. coli isolates were 
able to colonize on the ciprofloxacin containing 
plates even after curing off their plasmids. A 
similar mode of resistance has been studied in 
detail by Lindgren et al. (2003) (43). On the other 
hand, Paiva et al. (2012) (44) studied 
ciprofloxacin resistance gene in plasmid DNA of 
uropathogenic E. coli. The evolution of 
fluoroquinolone resistance has been found to be 
involved in the accumulation of multiple 
mutations in several genes, and it is ultimately 
reflected in the phenotype of the resistant 
organism. Therefore, the use of ciprofloxacin to 
treat patients should be restricted. Healthcare 
practitioners must think critically before 
prescribing the commonly used drugs to a patient. 
They should suggest a drug only after having the 
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